Eden Research (LON:EDEN) Issues Earnings Results

Eden Research (LON:EDEN) released its earnings results on Wednesday. The company reported GBX (0.36) earnings per share for the quarter, Digital Look Earnings reports. Eden Research had a negative return on equity of 15.05% and a negative net margin of 44.31%.

Eden Research Price Performance

LON:EDEN traded down GBX 0.03 on Friday, reaching GBX 2.17. The stock had a trading volume of 218,368 shares, compared to its average volume of 582,820. Eden Research has a 1-year low of GBX 1.96 and a 1-year high of GBX 5. The stock has a fifty day moving average price of GBX 2.70 and a 200-day moving average price of GBX 3.14. The company has a quick ratio of 2.42, a current ratio of 2.25 and a debt-to-equity ratio of 1.43. The company has a market capitalization of £17.42 million, a P/E ratio of -4.89 and a beta of 1.57.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.